Business
Biote Names John Denne as General Manager, Men’s Health Division
Mr. Denne to Accelerate Biote’s Expansion into Men’s Hormone Replacement Therapy Market IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading
About this update from Biote Corp.
[{"type":"text","content":"\nMr. Denne to Accelerate Biote’s Expansion into Men’s Hormone Replacement Therapy Market\n\n\n IRVING, Texas--(BUSINESS WIRE)--\nBiote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced that John Denne has joined the Company as General Manager, Men’s Health Division. In this role, Denne will lead Biote’s sales initiatives to expand the Company’s presence in the growing market for male hormone replacement therapy.\n\n\nA healthcare industry veteran, Denne joins Biote with more than 30 years of experience in sales, business development, strategic marketing and management. As Senior Director of Commercial Development at Endo International plc, a global specialty pharmaceuticals company, Denne was instrumental in driving the commercial success of new treatments in Men’s Health and Men’s Sexual Health division at the firm.\n\n\n“We’re thrilled to have John join the Biote team as we strengthen our focus on serving the men’s hormone replacement therapy market,” said Terry Weber, Biote Chief Executive Officer. “John has demonstrated an impressive track record of success in building brand recognition and helping companies scale business divisions to drive sustainable growth. We believe his extensive experience and leadership capabilities will accelerate our expansion into the substantial and underserved market for men’s health.”\n\n\n“I am excited to join Biote at this pivotal time of growth and expansion for the company. Hormone replacement therapy represents a safe and effective treatment option for millions of men, and I am eager to lead Biote’s strategic efforts to fulfill this largely unmet medical need,” Mr. Denne stated.\n\n\nMr. Denne began his career at Bristol Myers-Squibb, and subsequently held various sales, marketing and management roles at healthcare and pharmaceutical companies including Roche Pharmaceuticals, Sunovion Pharmaceuticals, Biopharm Communications and Auxilium / Endo Pharmaceuticals.\n\n\nAbout Biote\n\n\nBiote is transforming healthy aging through innovative, personalized hormone optimization therapies delivered by Biote-certified medical providers. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions, an underserved $7 billion global market, providing affordable sympt...